← 產業報告目錄

Endoscope Reprocessing Market by Product (AER, HLD & Test Strip, Detergent & Wipe, Endoscope Drying, Storage, & Transport System, Tracking Solution), Endoscope Type (Flexible, Rigid), End User (Hospital, ASC, Specialty Clinic) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-10頁數 298報告編號 MD5654

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global endoscope reprocessing market is projected to reach USD 4.24 billion by 2030 from USD 2.71 billion in 2025, at a CAGR of 9.4% during the forecast period. The global endoscope reprocessing market growth is mainly driven by the increasing number of endoscopic procedures, supported by the rising prevalence of gastrointestinal, respiratory, and urological conditions, as well as the growing geriatric population worldwide. Additionally, increased awareness of infection risks linked to contaminated or improperly disinfected endoscopes has led healthcare facilities to implement stricter reprocessing protocols, further increasing the demand for advanced reprocessing solutions. Furthermore, regulatory pressures and updated guidelines from global health authorities such as the FDA, CDC, and SGNA are encouraging safer and more standardized reprocessing practices. The rising adoption of automated reprocessing systems, higher investments in healthcare infrastructure, and the worldwide effort to improve patient safety are also fueling market growth. However, challenges like high capital costs and the complexity of reprocessing workflows may limit market expansion, especially in resource-limited regions. The flexible endoscopes segment accounted for the largest market share in the endoscope reprocessing market in 2024. The endoscope reprocessing market, by type of endoscope, is divided into flexible endoscopes and rigid endoscopes. In 2024, the flexible endoscopes segment led the market due to their widespread use in diagnostic and therapeutic procedures across gastroenterology, pulmonology, and urology. These scopes are favored because of their ability to access difficult-to-reach anatomical areas and provide greater patient comfort. The rising number of routine and advanced procedures, such as colonoscopies and bronchoscopies, which mainly use flexible scopes, has further increased the demand for effective reprocessing solutions to ensure safety and prevent cross-contamination. Additionally, regulatory focus on strict cleaning standards for complex devices like duodenoscopes is strengthening the adoption of reprocessing systems designed for flexible endoscopes. The hospitals & ambulatory surgery centers segment commanded the largest market share in 2024 and is expected to witness the highest CAGR from 2025 to 2030. By end user, the endoscope reprocessing market is segmented into hospitals & ambulatory surgery centers, specialty clinics, and other end users. The hospitals and ambulatory surgery centers segment holds the largest share of the endoscope reprocessing market in 2024 and is expected to grow faster during the forecast period, driven by the high volume of endoscopy procedures in these settings. Its growth is supported by factors such as the availability of advanced infrastructure, increased funding for infection prevention, and the adoption of automated reprocessing equipment to meet regulatory and accreditation standards. Furthermore, as hospitals seek to reduce healthcare-associated infections (HAIs) and comply with updated reprocessing protocols, the need for compliant and efficient systems is rapidly increasing. ASCs, offering cost savings and shorter patient turnaround times, are also experiencing a rise in endoscopic procedures, boosting the demand for high-throughput reprocessing solutions. Europe accounted for the second-largest share of the endoscope reprocessing market by region in 2024. The global endoscope reprocessing market is divided into five main regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe's endoscope reprocessing market is the second-largest regional market. This strong position is supported by robust healthcare infrastructure, regulatory enforcement on infection control, and the increasing burden of chronic diseases that require frequent endoscopic procedures and examinations. Among the European countries, Germany has the largest share, driven by its growing elderly population and increasing surgical procedures. According to the United Nations Population Division, Germany’s population aged 65 and older is expected to increase by 41%, reaching roughly 24 million by 2050, which will be about 30% of the total population. Additionally, the Financial Times reports that by 2050, more than half of Germany’s population will be aged 48 and older, with nearly a third exceeding 60 years. This demographic change is leading to a rise in age-related gastrointestinal, orthopedic, and cardiovascular conditions, resulting in greater demand for endoscopic procedures and boosting the need for advanced and reliable endoscope reprocessing systems to ensure infection control and safety standards. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30% • By Designation: C Level- 27%, Director Level- 18% and Others- 55% • By Region: North America- 35%, Europe- 30%, Asia Pacific- 22%, Latin America- 10%, and Middle East & Africa- 3% Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the endoscope reprocessing market are STERIS (Ireland), ASP (US), Olympus Corporation (Japan), Ecolab (US), Getinge AB (Sweden), HOYA Corporation (Japan), Conmed Corporation (US), Miele (Germany), Endo-Technik W. Griesat GmbH (UK), Fujifilm Holdings Corporation (Japan), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), and Metrex Research, LLC. (Canada), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), Medonica Co., Ltd. (South Korea), Shinva Medical Instrument Co., Ltd. (China), Micro-Scientific, LLC (US), Medalkan (Greece), Medical Devices Group Srl (Italy), SBSystem (Italy), Olive Health Care (India), MMM Group (Germany), Amity International (UK), and MİXTA MEDİKAL (Turkey), among others. Research Coverage This report examines the endoscope reprocessing market by products, type of endoscope, end user, and region. The report also explores factors such as drivers, restraints, opportunities, and challenges that influence market growth and provides details of the competitive landscape for market leaders. Additionally, it analyzes micro markets based on their individual growth trends. The report forecasts the revenue of market segments across five major regions and the respective countries within those regions. Reasons to Buy the Report The report will help both established and smaller firms to understand the market trends, which can then assist them in increasing their market share. Companies purchasing the report may use one or a combination of the strategies listed below to strengthen their market position presence. This report provides insights on the following points: analysis of key drivers (rising demand for endoscopy to diagnose and treat target diseases, elevated risk of endoscope-associated infections, expanding aging population, increasing emphasis on improving reprocessing guidelines by healthcare authorities, and rising adoption of minimally invasive surgeries), restraints (persistent concerns regarding safety and effectiveness of reprocessed endoscopic devices, potential health hazards associated with exposure to high-level chemical disinfectants, and high operational costs of endoscopic procedures coupled with limited reimbursement frameworks in emerging economies), opportunities (expanding medical devices industry in emerging economies and increased funding and investments for better healthcare infrastructure and endoscopy-related research), and challenges (rising demand for single-use endoscopes, increasing product failures and recalls, lack of adequately trained personnel, limited awareness among healthcare workers regarding standardized and effective reprocessing practices, and increasing FDA recommended measures to reduce infection transmission) • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the endoscope reprocessing market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the endoscope reprocessing market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the endoscope reprocessing market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 28 1.1 STUDY OBJECTIVES 28 1.2 MARKET DEFINITION 28 1.3 STUDY SCOPE 29 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 29 1.3.2 INCLUSIONS AND EXCLUSIONS 30 1.3.3 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 31 1.5 STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.1.1 List of key secondary sources 34 2.1.1.2 Key data from secondary sources 35 2.1.2 PRIMARY DATA 35 2.1.2.1 Key primary sources 36 2.1.2.2 Key objectives of primary research 36 2.1.2.3 Key data from primary sources 37 2.1.2.4 Key industry insights 38 2.1.2.5 Breakdown of primary interviews 38 2.2 MARKET SIZE ESTIMATION 39 2.2.1 BOTTOM-UP APPROACH 39 2.2.1.1 Company revenue estimation approach 40 2.2.1.1.1 Presentations of companies and primary interviews 40 2.2.1.1.2 Primary interviews 41 2.2.1.2 Growth forecast 41 2.2.1.3 Market segment assessment 42 2.2.2 TOP-DOWN APPROACH 42 2.3 DATA TRIANGULATION 43 2.4 MARKET SHARE ANALYSIS 44 2.5 RESEARCH ASSUMPTIONS 44 2.5.1 PARAMETRIC ASSUMPTIONS 44 2.5.2 GROWTH RATE ASSUMPTIONS 44 2.6 RESEARCH LIMITATIONS 45 2.6.1 METHODOLOGY-RELATED LIMITATIONS 45 2.6.2 SCOPE-RELATED LIMITATIONS 45 2.7 RISK ANALYSIS 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 50 4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW 50 4.2 ASIA PACIFIC ENDOSCOPE REPROCESSING MARKET, BY PRODUCT AND COUNTRY 51 4.3 ENDOSCOPE REPROCESSING MARKET, BY COUNTRY 52 4.4 ENDOSCOPE REPROCESSING MARKET, REGIONAL MIX, 2025 VS. 2030 53 4.5 ENDOSCOPE REPROCESSING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 54 5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 DRIVERS 56 5.2.1.1 Rising demand for endoscopy to diagnose and treat target diseases 56 5.2.1.2 Elevated risk of endoscope-associated infections 56 5.2.1.3 Booming geriatric population 57 5.2.1.4 Increasing emphasis on improving reprocessing guidelines 58 5.2.1.5 Growing adoption of minimally invasive surgeries 59 5.2.2 RESTRAINTS 59 5.2.2.1 Persistent concerns about safety and effectiveness of reprocessed endoscopic devices 59 5.2.2.2 Potential health hazards associated with exposure to high-level chemical disinfectants 60 5.2.2.3 High operational costs and limited reimbursement in developing economies 60 5.2.3 OPPORTUNITIES 61 5.2.3.1 Expanding medical devices industry 61 5.2.3.2 Increased funding and investments for healthcare infrastructure 61 5.2.4 CHALLENGES 62 5.2.4.1 Preference for single-use endoscopes 62 5.2.4.2 Increasing number of product failures and recalls 62 5.2.4.3 Lack of adequately trained personnel 63 5.2.4.4 Limited awareness about standardized and effective reprocessing practices 63 5.2.4.5 Increasing FDA-recommended measures to reduce infection transmission 64 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64 5.4 PRICING ANALYSIS 65 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 65 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 66 5.5 VALUE CHAIN ANALYSIS 67 5.6 SUPPLY CHAIN ANALYSIS 68 5.7 ECOSYSTEM ANALYSIS 69 5.8 INVESTMENT AND FUNDING SCENARIO 71 5.9 TECHNOLOGY ANALYSIS 72 5.9.1 KEY TECHNOLOGIES 72 5.9.1.1 Automated mechanical cleaning and disinfection 72 5.9.1.2 High-level chemical disinfection 72 5.9.2 COMPLEMENTARY TECHNOLOGIES 72 5.9.2.1 Low-temperature sterilization 72 5.10 PATENT ANALYSIS 73 5.11 TRADE ANALYSIS 75 5.11.1 IMPORT DATA FOR HS CODE 841920 75 5.11.2 EXPORT DATA FOR HS CODE 841920 75 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 76 5.13 REGULATORY ANALYSIS 77 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 5.13.2 REGULATORY FRAMEWORK 79 5.13.2.1 North America 79 5.13.2.1.1 US 79 5.13.2.1.2 Canada 79 5.13.2.2 Europe 79 5.13.2.2.1 Germany 79 5.13.2.2.2 Rest of Europe 80 5.13.2.3 Asia Pacific 80 5.13.2.3.1 Japan 80 5.13.2.3.2 Australia 80 5.13.2.3.3 Rest of Asia Pacific 80 5.13.2.4 Latin America 81 5.13.2.5 Middle East & Africa 81 5.14 PORTER’S FIVE FORCES ANALYSIS 81 5.14.1 THREAT OF NEW ENTRANTS 82 5.14.2 THREAT OF SUBSTITUTES 82 5.14.3 BARGAINING POWER OF BUYERS 83 5.14.4 BARGAINING POWER OF SUPPLIERS 83 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 83 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 84 5.15.2 KEY BUYING CRITERIA 84 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPE REPROCESSING MARKET 85 5.16.1 INTRODUCTION 85 5.16.2 MARKET POTENTIAL OF AI/GEN AI IN ENDOSCOPE REPROCESSING MARKET 85 5.16.3 AI USE CASES 86 5.16.4 FUTURE OF AI/GEN AI IN ENDOSCOPE REPROCESSING ECOSYSTEM 86 5.17 IMPACT OF 2025 US TARIFF REGULATION ON ENDOSCOPE REPROCESSING MARKET 87 5.17.1 INTRODUCTION 87 5.17.2 KEY TARIFF RATES 87 5.17.3 PRICE IMPACT ANALYSIS 88 5.17.4 KEY IMPACT ON COUNTRY/REGION 88 5.17.4.1 North America 88 5.17.4.1.1 US 88 5.17.4.2 Europe 88 5.17.4.3 Asia Pacific 88 5.17.5 IMPACT ON END-USE INDUSTRIES 89 5.17.5.1 Hospitals 89 5.17.5.2 Ambulatory care centers 89 6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT 90 6.1 INTRODUCTION 91 6.2 ENDOSCOPE REPROCESSING EQUIPMENT 91 6.2.1 AUTOMATED ENDOSCOPE REPROCESSORS 94 6.2.1.1 Automated endoscope reprocessors, by portability 98 6.2.1.1.1 Standalone automated endoscope reprocessors 98 6.2.1.1.2 Portable automated endoscope reprocessors 101 6.2.1.2 Automated endoscope reprocessors, by type 103 6.2.1.2.1 Single-basin automated endoscope reprocessors 104 6.2.1.2.2 Double-basin automated endoscope reprocessors 107 6.2.2 ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS 110 6.2.2.1 Need for patient safety and efficient reprocessing workflow to accelerate growth 110 6.3 ENDOSCOPE REPROCESSING CONSUMABLES 114 6.3.1 DETERGENTS & WIPES 117 6.3.1.1 Rising focus on pre-cleaning protocols to aid growth 117 6.3.2 HIGH-LEVEL DISINFECTANTS & TEST STRIPS 120 6.3.2.1 Growing number of infection outbreaks to drive market 120 6.3.3 OTHER PRODUCTS 123 6.4 ENDOSCOPE TRACKING SOLUTIONS 127 6.4.1 IMPROVED TRACEABILITY AND SUPERVISION TO FOSTER GROWTH 127 7 ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE 131 7.1 INTRODUCTION 132 7.2 FLEXIBLE ENDOSCOPES 132 7.2.1 REAL-TIME IMAGING CAPABILITIES TO CONTRIBUTE TO GROWTH 132 7.3 RIGID ENDOSCOPES 135 7.3.1 SUPERIOR IMAGE RESOLUTION AND ENHANCED STABILITY TO SPUR GROWTH 135 8 ENDOSCOPE REPROCESSING MARKET, BY END USER 139 8.1 INTRODUCTION 140 8.2 HOSPITALS & ASCS 140 8.2.1 RISE IN INFECTION CASES TO FACILITATE GROWTH 140 8.3 SPECIALTY CLINICS 144 8.3.1 NEED TO MAINTAIN HIGH STANDARDS OF SAFETY AND QUALITY TO FOSTER GROWTH 144 8.4 OTHER END USERS 146 9 ENDOSCOPE REPROCESSING MARKET, BY REGION 150 9.1 INTRODUCTION 151 9.2 NORTH AMERICA 151 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 151 9.2.2 US 156 9.2.2.1 Rising incidence of colorectal cancer to augment growth 156 9.2.3 CANADA 160 9.2.3.1 High prevalence of hospital-acquired infections to promote growth 160 9.3 EUROPE 164 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 164 9.3.2 GERMANY 168 9.3.2.1 Aging population and increasing disease burden to support growth 168 9.3.3 UK 171 9.3.3.1 Increasing use of endoscopy procedures to foster growth 171 9.3.4 FRANCE 175 9.3.4.1 Strong public investment in healthcare infrastructure to aid growth 175 9.3.5 ITALY 178 9.3.5.1 Growing geriatric population to drive market 178 9.3.6 SPAIN 181 9.3.6.1 Demographic shift and increasing number of specialized care personnel to expedite growth 181 9.3.7 REST OF EUROPE 184 9.4 ASIA PACIFIC 188 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 189 9.4.2 JAPAN 192 9.4.2.1 Increasing number of endoscopic surgeries to spur growth 192 9.4.3 CHINA 195 9.4.3.1 Rising elderly population to facilitate growth 195 9.4.4 INDIA 198 9.4.4.1 Improved healthcare infrastructure and booming healthcare tourism to bolster growth 198 9.4.5 AUSTRALIA 201 9.4.5.1 Growing number of age-related illnesses to boost market 201 9.4.6 REST OF ASIA PACIFIC 204 9.5 LATIN AMERICA 207 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 208 9.5.2 BRAZIL 211 9.5.2.1 Need to maintain hygiene and safety standards to boost market 211 9.5.3 MEXICO 214 9.5.3.1 Rising cancer burden to accelerate growth 214 9.5.4 REST OF LATIN AMERICA 217 9.6 MIDDLE EAST & AFRICA 220 9.6.1 EMERGING STANDARDS FOR REPROCESSING TO AUGMENT GROWTH 220 10 COMPETITIVE LANDSCAPE 225 10.1 INTRODUCTION 225 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 225 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET 225 10.3 REVENUE ANALYSIS, 2020–2024 227 10.4 MARKET SHARE ANALYSIS, 2024 228 10.5 COMPANY VALUATION AND FINANCIAL METRICS 230 10.6 BRAND/PRODUCT COMPARISON 231 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 231 10.7.1 STARS 231 10.7.2 EMERGING LEADERS 231 10.7.3 PERVASIVE PLAYERS 232 10.7.4 PARTICIPANTS 232 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 233 10.7.5.1 Company footprint 233 10.7.5.2 Region footprint 233 10.7.5.3 Product footprint 234 10.7.5.4 End-user footprint 234 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 235 10.8.1 PROGRESSIVE COMPANIES 235 10.8.2 RESPONSIVE COMPANIES 235 10.8.3 DYNAMIC COMPANIES 235 10.8.4 STARTING BLOCKS 235 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 237 10.8.5.1 Detailed list of key startups/SMEs 237 10.8.5.2 Competitive benchmarking of key startups/SMEs 237 10.9 COMPETITIVE SCENARIO 238 10.9.1 PRODUCT LAUNCHES 238 10.9.2 DEALS 239 10.9.3 EXPANSIONS 240 10.9.4 OTHER DEVELOPMENTS 240 11 COMPANY PROFILES 241 11.1 KEY PLAYERS 241 11.1.1 STERIS 241 11.1.1.1 Business overview 241 11.1.1.2 Products offered 242 11.1.1.3 MnM view 246 11.1.1.3.1 Key strengths 246 11.1.1.3.2 Strategic choices 246 11.1.1.3.3 Weaknesses and competitive threats 246 11.1.2 ASP 247 11.1.2.1 Business overview 247 11.1.2.2 Products offered 248 11.1.2.3 MnM view 249 11.1.2.3.1 Key strengths 249 11.1.2.3.2 Strategic choices 249 11.1.2.3.3 Weaknesses and competitive threats 249 11.1.3 OLYMPUS CORPORATION 250 11.1.3.1 Business overview 250 11.1.3.2 Products offered 251 11.1.3.3 Recent developments 253 11.1.3.3.1 Product launches 253 11.1.3.3.2 Expansions 253 11.1.3.4 MnM view 254 11.1.3.4.1 Key strengths 254 11.1.3.4.2 Strategic choices 254 11.1.3.4.3 Weaknesses and competitive threats 254 11.1.4 GETINGE AB 255 11.1.4.1 Business overview 255 11.1.4.2 Products offered 256 11.1.4.3 Recent developments 258 11.1.4.3.1 Product launches 258 11.1.4.3.2 Deals 258 11.1.5 ECOLAB INC. 259 11.1.5.1 Business overview 259 11.1.5.2 Products offered 260 11.1.5.3 Recent developments 261 11.1.5.3.1 Other developments 261 11.1.6 HOYA CORPORATION 262 11.1.6.1 Business overview 262 11.1.6.2 Products offered 263 11.1.6.3 Recent developments 265 11.1.6.3.1 Deals 265 11.1.7 CONMED CORPORATION 266 11.1.7.1 Business overview 266 11.1.7.2 Products offered 268 11.1.8 THE MIELE GROUP 269 11.1.8.1 Business overview 269 11.1.8.2 Products offered 269 11.1.8.3 Recent developments 270 11.1.8.3.1 Deals 270 11.1.9 ARC HEALTHCARE SOLUTIONS 271 11.1.9.1 Business overview 271 11.1.9.2 Products offered 271 11.1.10 METREX RESEARCH, LLC 273 11.1.10.1 Business overview 273 11.1.10.2 Products offered 273 11.2 OTHER PLAYERS 274 11.2.1 MEDALKAN 274 11.2.2 MICRO-SCIENTIFIC, LLC 275 11.2.3 ENDO-TECHNIK W. GRIESAT GMBH 276 11.2.4 BES HEALTHCARE LTD 277 11.2.5 FUJIFILM HOLDINGS CORPORATION 278 11.2.6 BORER CHEMIE AG 279 11.2.7 MEDONICA CO. LTD 280 11.2.8 TUTTNAUER 281 11.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD. 282 11.2.10 SBSYSTEM 283 11.2.11 OLIVE HEALTH CARE 284 11.2.12 MMM GROUP 285 11.2.13 AMITY INTERNATIONAL 286 11.2.14 MİXTA MEDİKAL 287 11.2.15 MEDICAL DEVICES GROUP SRL 288 12 APPENDIX 289 12.1 DISCUSSION GUIDE 289 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 294 12.3 CUSTOMIZATION OPTIONS 296 12.4 RELATED REPORTS 296 12.5 AUTHOR DETAILS 297
圖表清單 List of Tables & Figures
TABLE 1 ENDOSCOPE REPROCESSING MARKET: INCLUSIONS AND EXCLUSIONS 30 TABLE 2 EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2023–2025 31 TABLE 3 EXCHANGE RATES USED FOR CONVERSION OF SEK TO USD, 2022–2024 31 TABLE 4 ENDOSCOPE REPROCESSING MARKET: KEY DATA FROM PRIMARY SOURCES 37 TABLE 5 ENDOSCOPE REPROCESSING MARKET: PARAMETRIC ASSUMPTIONS 44 TABLE 6 ENDOSCOPE REPROCESSING MARKET: RISK ANALYSIS 45 TABLE 7 AVERAGE SELLING PRICE TREND OF ENDOSCOPE REPROCESSING DEVICES, BY KEY PLAYER, 2022–2024 (USD) 66 TABLE 8 AVERAGE SELLING PRICE TREND OF ENDOSCOPE REPROCESSING DEVICES, BY REGION, 2022–2024 (USD) 66 TABLE 9 ENDOSCOPE REPROCESSING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 70 TABLE 10 ENDOSCOPE REPROCESSING MARKET: LIST OF PATENTS/PATENT REGISTRATIONS, 2023–2024 74 TABLE 11 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2020–2024 (USD THOUSAND) 75 TABLE 12 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2020–2024 (USD THOUSAND) 75 TABLE 13 ENDOSCOPE REPROCESSING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 76 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 19 ENDOSCOPE REPROCESSING MARKET: PORTER’S FIVE FORCES 81 TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 84 TABLE 21 KEY BUYING CRITERIA, BY END USER 85 TABLE 22 US ADJUSTED RECIPROCAL TARIFF RATES 87 TABLE 23 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91 TABLE 24 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 92 TABLE 25 ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION) 92 TABLE 26 NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 27 EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 28 ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 29 LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 30 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS 95 TABLE 31 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 32 NORTH AMERICA: AUTOMATED ENDOSCOPE RREPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 33 EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 34 ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 35 LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 36 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 98 TABLE 37 STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 38 NORTH AMERICA: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 39 EUROPE: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 40 ASIA PACIFIC: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 41 LATIN AMERICA: STANDALONE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 42 PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION) 101 TABLE 43 NORTH AMERICA: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 44 EUROPE: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 45 ASIA PACIFIC: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 46 LATIN AMERICA: PORTABLE AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 47 AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 48 MANUFACTURERS AND RESPECTIVE SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSOR MODELS 104 TABLE 49 SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 50 NORTH AMERICA: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 51 EUROPE: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 52 ASIA PACIFIC: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 53 LATIN AMERICA: SINGLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 54 MANUFACTURERS AND RESPECTIVE DUAL-BASIN AUTOMATED ENDOSCOPE REPROCESSOR MODELS 107 TABLE 55 DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 56 NORTH AMERICA: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 57 EUROPE: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 58 ASIA PACIFIC: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 59 LATIN AMERICA: DOUBLE-BASIN AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 60 ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS OFFERED BY KEY PLAYERS 111 TABLE 61 ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 62 NORTH AMERICA: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 63 EUROPE: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 64 ASIA PACIFIC: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 65 LATIN AMERICA: ENDOSCOPE DRYING, STORAGE, AND TRANSPORT SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 66 ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 67 ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 68 NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 69 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 70 ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 71 LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 72 ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 73 NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 74 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 75 ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 76 LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR DETERGENTS & WIPES, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 77 ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 78 NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 79 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 80 ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 81 LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR HIGH-LEVEL DISINFECTANTS & TEST STRIPS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 82 OTHER REPROCESSING CONSUMABLE PRODUCTS OFFERED BY MANUFACTURERS 124 TABLE 83 ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 84 NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 85 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 86 ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 87 LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 88 ENDOSCOPE TRACKING SOLUTIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 89 NORTH AMERICA: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 90 EUROPE: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 91 ASIA PACIFIC: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 92 LATIN AMERICA: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 93 ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 132 TABLE 94 ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 95 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 96 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 97 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 98 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 99 ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 100 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 101 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 102 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 103 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 104 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 105 HOSPITALS PER CAPITA, BY COUNTRY, 2024 141 TABLE 106 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 107 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 108 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 109 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 110 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 111 ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 112 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 113 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 114 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 115 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 116 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 117 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 118 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 119 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 120 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 121 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 122 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 151 TABLE 123 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 124 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 153 TABLE 125 NORTH AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 126 NORTH AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 127 NORTH AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 155 TABLE 128 NORTH AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 129 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 156 TABLE 130 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 131 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2025 157 TABLE 132 US: INSTALLATION BASE OF AUTOMATED ENDOSCOPE REPROCESSORS IN HOSPITALS, 2023–2030 (UNITS) 158 TABLE 133 US: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 158 TABLE 134 US: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 135 US: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 136 US: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 159 TABLE 137 US: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 138 US: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 160 TABLE 139 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 140 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 141 CANADA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 142 CANADA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 143 CANADA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 162 TABLE 144 CANADA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 145 CANADA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 163 TABLE 146 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 147 EUROPE: KEY MACROECONOMIC INDICATORS 164 TABLE 148 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 149 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 150 EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 151 EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 152 EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 167 TABLE 153 EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 154 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 167 TABLE 155 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 156 GERMANY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 157 GERMANY: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 158 GERMANY: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 159 GERMANY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 170 TABLE 160 GERMANY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 161 GERMANY: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 171 TABLE 162 GERMANY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 163 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 172 TABLE 164 UK: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 165 UK: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 166 UK: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 173 TABLE 167 UK: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 168 UK: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 174 TABLE 169 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 170 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 171 FRANCE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 172 FRANCE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 173 FRANCE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 177 TABLE 174 FRANCE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 175 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 178 TABLE 176 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 177 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179 TABLE 178 ITALY: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 179 ITALY: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 180 ITALY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 180 TABLE 181 ITALY: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 182 ITALY: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 181 TABLE 183 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 181 TABLE 184 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182 TABLE 185 SPAIN: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 186 SPAIN: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 187 SPAIN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 183 TABLE 188 SPAIN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 189 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 184 TABLE 190 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 191 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 192 REST OF EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 193 REST OF EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 194 REST OF EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 186 TABLE 195 REST OF EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 196 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 187 TABLE 197 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 198 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 189 TABLE 199 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 200 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 201 ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 202 ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 203 ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 191 TABLE 204 ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 205 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 192 TABLE 206 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 207 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 208 JAPAN: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 209 JAPAN: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 210 JAPAN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 194 TABLE 211 JAPAN: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 212 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 195 TABLE 213 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 214 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 215 CHINA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 216 CHINA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 217 CHINA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 197 TABLE 218 CHINA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 219 CHINA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 198 TABLE 220 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 198 TABLE 221 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 222 INDIA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 223 INDIA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 224 INDIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 200 TABLE 225 INDIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 226 INDIA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 201 TABLE 227 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 228 AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 202 TABLE 229 AUSTRALIA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 230 AUSTRALIA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 231 AUSTRALIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 203 TABLE 232 AUSTRALIA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 233 AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 204 TABLE 234 AUSTRALIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 235 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 205 TABLE 236 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 237 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 238 REST OF ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 206 TABLE 239 REST OF ASIA PACIFIC: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 240 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 207 TABLE 241 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 207 TABLE 242 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 208 TABLE 243 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 244 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 209 TABLE 245 LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 246 LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 247 LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 210 TABLE 248 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 249 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 211 TABLE 250 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 211 TABLE 251 BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 212 TABLE 252 BRAZIL: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 253 BRAZIL: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 254 BRAZIL: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 213 TABLE 255 BRAZIL: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 256 BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 214 TABLE 257 BRAZIL: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 214 TABLE 258 MEXICO: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 215 TABLE 259 MEXICO: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 260 MEXICO: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 261 MEXICO: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 216 TABLE 262 MEXICO: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 263 MEXICO: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 217 TABLE 264 MEXICO: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 265 REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 218 TABLE 266 REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 267 REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 268 REST OF LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 219 TABLE 269 REST OF LATIN AMERICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 270 REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 220 TABLE 271 REST OF LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 272 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 221 TABLE 273 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 274 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 275 MIDDLE EAST & AFRICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 222 TABLE 276 MIDDLE EAST & AFRICA: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 277 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2023–2030 (USD MILLION) 223 TABLE 278 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 279 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 223 TABLE 280 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, JANUARY 2022–JULY 2025 225 TABLE 281 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION 228 TABLE 282 ENDOSCOPE REPROCESSING MARKET: REGION FOOTPRINT 233 TABLE 283 ENDOSCOPE REPROCESSING MARKET: PRODUCT FOOTPRINT 234 TABLE 284 ENDOSCOPE REPROCESSING MARKET: END-USER FOOTPRINT 234 TABLE 285 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 237 TABLE 286 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 237 TABLE 287 ENDOSCOPE REPROCESSING MARKET: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 238 TABLE 288 ENDOSCOPE REPROCESSING MARKET: DEALS, JANUARY 2022–JULY 2025 239 TABLE 289 ENDOSCOPE REPROCESSING MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 240 TABLE 290 ENDOSCOPE REPROCESSING MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 240 TABLE 291 STERIS: COMPANY OVERVIEW 241 TABLE 292 STERIS: PRODUCTS OFFERED 242 TABLE 293 ASP: COMPANY OVERVIEW 247 TABLE 294 ASP: PRODUCTS OFFERED 248 TABLE 295 OLYMPUS CORPORATION: COMPANY OVERVIEW 250 TABLE 296 OLYMPUS CORPORATION: PRODUCTS OFFERED 251 TABLE 297 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 253 TABLE 298 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 253 TABLE 299 GETINGE AB: COMPANY OVERVIEW 255 TABLE 300 GETINGE AB: PRODUCTS OFFERED 256 TABLE 301 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 258 TABLE 302 GETINGE AB: DEALS, JANUARY 2022–JULY 2025 258 TABLE 303 ECOLAB INC.: COMPANY OVERVIEW 259 TABLE 304 ECOLAB INC.: PRODUCTS OFFERED 260 TABLE 305 ECOLAB INC.: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 261 TABLE 306 HOYA CORPORATION: COMPANY OVERVIEW 262 TABLE 307 HOYA CORPORATION: PRODUCTS OFFERED 263 TABLE 308 HOYA CORPORATION: DEALS, JANUARY 2022–JULY 2025 265 TABLE 309 CONMED CORPORATION: COMPANY OVERVIEW 266 TABLE 310 CONMED CORPORATION: PRODUCTS OFFERED 268 TABLE 311 THE MIELE GROUP: COMPANY OVERVIEW 269 TABLE 312 THE MIELE GROUP: PRODUCTS OFFERED 269 TABLE 313 THE MIELE GROUP: DEALS, JANUARY 2022–JULY 2025 270 TABLE 314 ARC HEALTHCARE SOLUTIONS: COMPANY OVERVIEW 271 TABLE 315 ARC HEALTHCARE SOLUTIONS: PRODUCTS OFFERED 271 TABLE 316 METREX RESEARCH, LLC: COMPANY OVERVIEW 273 TABLE 317 METREX RESEARCH, LLC: PRODUCTS OFFERED 273 TABLE 318 MEDALKAN: COMPANY OVERVIEW 274 TABLE 319 MICRO-SCIENTIFIC, LLC: COMPANY OVERVIEW 275 TABLE 320 ENDO-TECHNIK W. GRIESAT GMBH: COMPANY OVERVIEW 276 TABLE 321 BES HEALTHCARE LTD: COMPANY OVERVIEW 277 TABLE 322 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 278 TABLE 323 BORER CHEMIE AG: COMPANY OVERVIEW 279 TABLE 324 MEDONICA CO. LTD: COMPANY OVERVIEW 280 TABLE 325 TUTTNAUER: COMPANY OVERVIEW 281 TABLE 326 SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW 282 TABLE 327 SBSYSTEM: COMPANY OVERVIEW 283 TABLE 328 OLIVE HEALTH CARE: COMPANY OVERVIEW 284 TABLE 329 MMM GROUP: COMPANY OVERVIEW 285 TABLE 330 AMITY INTERNATIONAL: COMPANY OVERVIEW 286 TABLE 331 MİXTA MEDİKAL: COMPANY OVERVIEW 287 TABLE 332 MEDICAL DEVICES GROUP SRL: COMPANY OVERVIEW 288 FIGURE 1 ENDOSCOPE REPROCESSING MARKET SEGMENTATION AND REGIONAL SCOPE 29 FIGURE 2 ENDOSCOPE REPROCESSING MARKET: YEARS CONSIDERED 30 FIGURE 3 ENDOSCOPE REPROCESSING MARKET: RESEARCH DESIGN 33 FIGURE 4 ENDOSCOPE REPROCESSING MARKET: KEY DATA FROM SECONDARY SOURCES 35 FIGURE 5 ENDOSCOPE REPROCESSING MARKET: KEY PRIMARY SOURCES 36 FIGURE 6 ENDOSCOPE REPROCESSING MARKET: KEY INDUSTRY INSIGHTS 38 FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 38 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39 FIGURE 9 ENDOSCOPE REPROCESSING MARKET: COMPANY REVENUE ESTIMATION, 2024 40 FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41 FIGURE 11 ENDOSCOPE REPROCESSING MARKET: TOP-DOWN APPROACH 42 FIGURE 12 ENDOSCOPE REPROCESSING MARKET: DATA TRIANGULATION 43 FIGURE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 46 FIGURE 14 ENDOSCOPE REPROCESSING MARKET, BY TYPE OF ENDOSCOPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 15 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 48 FIGURE 16 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET 49 FIGURE 17 INCREASING VOLUME OF ENDOSCOPIC PROCEDURES TO DRIVE MARKET 50 FIGURE 18 ENDOSCOPE REPROCESSING CONSUMABLES SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024 51 FIGURE 19 GERMANY TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 52 FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 53 FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 54 FIGURE 22 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 23 NEW REVENUE POCKETS FOR PLAYERS IN ENDOSCOPE REPROCESSING MARKET 65 FIGURE 24 ENDOSCOPE REPROCESSING MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 25 ENDOSCOPE REPROCESSING MARKET: SUPPLY CHAIN ANALYSIS 69 FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 70 FIGURE 27 ENDOSCOPE REPROCESSING MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2025 71 FIGURE 28 ENDOSCOPE REPROCESSING MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 73 FIGURE 29 ENDOSCOPE REPROCESSING MARKET: PORTER’S FIVE FORCES ANALYSIS 82 FIGURE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER 84 FIGURE 31 KEY BUYING CRITERIA, BY END USER 84 FIGURE 32 KEY AI USE CASES IN ENDOSCOPE REPROCESSING MARKET 86 FIGURE 33 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 152 FIGURE 34 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 188 FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, 2020–2024 227 FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET, 2024 228 FIGURE 37 EV/EBITDA OF KEY VENDORS, 2025 230 FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 230 FIGURE 39 ENDOSCOPE REPROCESSING MARKET: BRAND/PRODUCT COMPARISON 231 FIGURE 40 ENDOSCOPE REPROCESSING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 232 FIGURE 41 ENDOSCOPE REPROCESSING MARKET: COMPANY FOOTPRINT 233 FIGURE 42 ENDOSCOPE REPROCESSING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 236 FIGURE 43 STERIS: COMPANY SNAPSHOT (2025) 242 FIGURE 44 ASP: COMPANY SNAPSHOT (2024) 248 FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 251 FIGURE 46 GETINGE AB: COMPANY SNAPSHOT (2024) 256 FIGURE 47 ECOLAB INC.: COMPANY SNAPSHOT (2024) 260 FIGURE 48 HOYA CORPORATION: COMPANY SNAPSHOT (2025) 263 FIGURE 49 CONMED CORPORATION: COMPANY SNAPSHOT (2024) 267

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們